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Summary
Background Transforming growth factor (TGF)-b is an important modulator of
immune functions and cellular responses, such as differentiation, proliferation,
migration and apoptosis. The Smad proteins, which are intracellular TGF-b signal
transducers, mediate most actions of TGF-b.
Objectives This study examines the role of Smad3 in a murine model of contact
hypersensitivity (CHS).
Methods The CHS response to oxazolone was studied in Smad3-deﬁcient mice. The
ear swelling response was measured and skin biopsies from oxazolone-sensitized
skin areas were obtained for RNA isolation, immunohistochemical analyses and
histology. Ear draining lymph nodes were collected for RNA isolation and prolif-
eration tests. Quantitative real-time polymerase chain reaction was used to quan-
tify mRNA expression of cytokines, chemokines and transcription factors.
Results The expression of proinﬂammatory [interleukin (IL)-1b, tumour necrosis
factor-a, IL-6], Th2 (IL-4) and Th17 type cytokines (IL-17), as well as regulatory
components (TGF-b, Foxp3) increased signiﬁcantly at the mRNA level in the skin
of oxazolone-treated Smad3)⁄) mice when compared with wild-type controls.
The expression of the Th1 type cytokine IFN-c and the chemokines CXCL9 and
CXCL10 was, however, unaffected by the lack of Smad3. The number of neu-
trophils and expression of the chemokines CCL3 and CXCL5, which are both
involved in neutrophil recruitment, were increased in mice lacking Smad3. Also
Th2 type chemokines CCL24, CCL3 and CXCL5 were increased in the skin of
Smad3)⁄) mice compared with wild-type mice. In the lymph nodes, mRNA of
IL-1b and IL-17, but not IL-4, TGF-b or Foxp3, was increased in Smad3)⁄)
mice during the CHS response.
Conclusions The lack of intact TGF-b signalling via Smad3 results in an increased
proinﬂammatory, Th2 and Th17 type response in the skin, as well as increased
expression of regulatory elements such as TGF-b and Foxp3. Understanding the
role of Smad3 in the CHS response may offer treatment and prevention strategies
in this often disabling disease.
Allergic contact dermatitis (ACD) is an inﬂammatory response
occurring at the site of hapten challenge in sensitized individ-
uals. It has a chronic course with relapses occurring at every
contact with the allergen. ACD is a major occupational and
environmental dermatological health problem, often causing
work disability due to occupational exposure to contact aller-
gens (haptens).
1 The inﬂammatory inﬁltrate in ACD is com-
posed of CD8+ and CD4+ T cells, dendritic cells (DCs),
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neutrophils.
2–5 Cytokines produced by T-helper (Th) 1 and
Th2 type cells are involved in the expression of contact hyper-
sensitivity (CHS).
2,3,6,7
Transforming growth factor (TGF)-b is a multifunctional
cytokine involved in diverse biological processes ranging
from cell differentiation and tissue repair to development of
tumours and inﬂammation. The importance of TGF-b signal-
ling is evident from the severe immune pathology seen in
TGF-b knockout mice.
8 TGF-b is most commonly considered
an anti-inﬂammatory cytokine, inhibiting Th1 and Th2 dif-
ferentiation and the production of, and response to, cyto-
kines associated with both subtypes.
8,9 TGF-b also exerts
potent inhibitory effects on macrophages and DCs, and
induces the differentiation of T-regulatory cells (Tregs).
10–12
Paradoxically, several proinﬂammatory mechanisms have also
been described, including a role in mice for TGF-b in the
differentiation of Th17 cells. Th17 cells, which have been
linked to the pathogenesis of several inﬂammatory and auto-
immune diseases, including CHS,
13 require in the mouse
TGF-b, interleukin (IL)-1b, IL-6 and the transcription factor
RORct for their differentiation.
14,15 Furthermore, TGF-b is a
strong chemoattractant for leucocytes and modulates the
expression of adhesion molecules.
8 The analysis of the role
of TGF-b in the immune system is complicated by the fact
that most tissues produce TGF-b and express receptors for
TGF-b.
The general pathway of TGF-b signalling involves the
binding of mature TGF-b1 to the TGF-b type II receptor,
which in turn activates the TGF-b type I receptor (TGFbRI).
Upon activation, TGFbRI phosphorylates intracellular media-
tors called Smad proteins, which are central in most actions
of TGF-b.
16,17 The Smads include receptor-speciﬁc Smads
(R-Smad1, 2, 3, 5 and 8), the common Smad (Co-Smad4)
and inhibitory Smads (I-Smad6 and 7). The phosphorylated
R-Smads form protein complexes with Smad4 molecules
which subsequently translocate into the nucleus where they
regulate transcription of target genes.
17 I-Smads are also
induced by TGF-b family ligands, but terminate or reduce
the strength of the signal.
The generation of mice deﬁcient in Smads has made it pos-
sible to investigate the relative role of these mediators of TGF-
b signalling in vivo. Unlike the targeted disruptions of Smad2
and 4 which are lethal, mice with targeted disruption of
Smad3 are viable and survive to adulthood (up to approxi-
mately 8 months of age).
18 Eventually, Smad3 knockout mice
develop progressive illness including leucocytosis, massive
inﬂammation and impaired mucosal immunity.
19 Smad3 has
been shown to play an important role in mediating TGF-b
signals in T cells, neutrophils and monocytes, and has a role
in mediating antiproliferative effects of TGF-b as well as
immunomodulatory effects such as the regulation of cytokine
production.
19–21 The loss of Smad3 makes mice resistant to
chemically induced skin cancer, which is both stimulated and
inhibited by inﬂammation.
22 In humans, Smad3 mRNA
expression is signiﬁcantly higher in healthy skin of controls
as compared with lesional skin of patients with atopic
dermatitis.
23
In this study, the Smad3 knockout mouse model was used
to investigate the in vivo role of the TGF-b⁄Smad3 pathway in
CHS. The results show that in this murine model Smad3 regu-
lates the allergic inﬂammation by modifying the expression of
cytokines and chemokines, as well as the inﬁltration of local
inﬂammatory cells.
Materials and methods
Mice and sensitization
Smad3
ex8 ⁄ex8 knockout mice of C57BL6 background were
kindly provided by Dr Chuxia Deng (NIH, Bethesda, MD,
U.S.A.) and bred in our facilities. The resulting progeny were
screened by polymerase chain reaction (PCR) to identify
Smad3)⁄) and wild-type (WT) mice. The mice were kept
under pathogen-free conditions. All procedures performed
were in accordance with instructions and permissions of the
Health Services of the State Provincial Ofﬁce of Southern
Finland.
Male or female mice aged 7–10 weeks (age- and sex-
matched within each experiment; n = 5–11 mice per group)
were topically sensitized to oxazolone according to the
method described by Lauerma et al.
24 The mice were lightly
anaesthetized by inhaled Isoﬂuran (Abbott Laboratories,
Abbott Park, IL, U.S.A.), their back skin shaved (4 cm
2), tape-
stripped three times, and sensitized to oxazolone (50 lL,
10 mg mL
)1) in a 4 : 1 acetone : olive oil solution on day 0.
A control group (n = 3–12 mice per group) was treated simi-
larly with vehicle only. On day 7, oxazolone was re-applied
on the back skin (50 lL, 1 mg mL
)1) and the ear pinnae
(25 lL, 1 mg mL
)1). The resulting thickness of the antigen-
challenged ears was measured using a micrometer (Mitutoyo,
Kanagawa, Japan), before challenge and at 24 and 48 h after
challenge. Increased ear thickness is expressed as mean ± SEM.
The mice were killed at 48 h and ear draining lymph nodes,
ear pinnae and skin biopsies were collected for further analy-
sis. Ear pinnae of approximately equal area were weighed,
expressed as mean ± SEM. All experiments were repeated
twice.
Histological analysis and immunohistochemistry
Skin biopsies from allergen-exposed areas obtained at 48 h
postexposure were ﬁxed in 10% buffered formalin, embedded
in parafﬁn and cut into 4 lm thick sections. The skin sections
were stained with haematoxylin and eosin and toluidine blue,
and examined for lymphocytes, eosinophils and neutrophils
under light microscopy. Inﬂammatory cell types were coun-
ted in 15 high-power ﬁelds at · 1000 magniﬁcation and
expressed as cells per high-power ﬁeld.
Frozen, allergen-exposed ear pinnae were stored at )80  C
and embedded in OCT compound until sectioned, ﬁxed in
cold acetone, and peroxidase stained with rat antimouse CD3
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RM4-5) purchased from BD Pharmingen (San Diego, CA,
U.S.A.) and with rat antimouse Foxp3 (clone FJK-16s) pur-
chased from eBioscience (San Diego, CA, U.S.A.). Biotin-
conjugated secondary Ab antirat IgG (H + L) was purchased
from Vector Laboratories (Burlingame, CA, U.S.A.).
Proliferation test
To reﬂect lymph node activity in vivo, lymph node cell prolif-
eration was measured with no stimulating antigen immediate-
ly after isolation. Lymph node cells were seeded at 1 · 10
5
cells per well, suspended in complete RPMI-1640 medium
with Glutamax (Invitrogen Life Technologies, San Diego, CA,
U.S.A.) in 96-well plates, after which 1 lCi [
3H] thymidine
per well was added. After 36 h of incubation at 37  C⁄5%
CO2, incorporated radioactivity was determined with a liquid
scintillation counter (Trilux 1450 Microbeta; Wallac, Turku,
Finland). Results are expressed as mean counts per minute of
triplicate wells.
RNA isolation and cDNA synthesis
Skin biopsies and ear draining lymph nodes were collected at
48 h after allergen challenge. The tissue samples were imme-
diately snap frozen on dry ice and kept at )80  C until
homogenized with an Ultra-Turrax T8 (IKA Labortechnik,
Staufen, Germany) in TRIzol (Invitrogen Life Technologies).
RNA extraction was performed according to TRIzol instruc-
tions, followed by DNAseI (RNase-free; Invitrogen Life Tech-
nologies) treatment to remove contaminating genomic DNA,
and further extraction with phenol-chloroform-isoamylalcohol
(25 : 24 : 1). One microgram of extracted RNA was reverse
transcribed into cDNA using MultiScribe reverse transcriptase
and random hexamers (Applied Biosystems, Foster City, CA,
U.S.A.).
Real-time quantitative polymerase chain reaction
Quantitative real-time PCR (TaqMan) analysis was performed
with ABI Prism 7700 Sequence Detector System (Applied Bio-
systems) as described previously.
25 Primers and target-speciﬁc
probes were purchased as predeveloped reagents [IL-1b, IL-6,
tumour necrosis factor (TNF)-a, IL-4, IL-17, IL-10, Foxp3,
CXCL9⁄MIG, CXCL10⁄IP10, CCL3⁄MIP-1a, CXCL5⁄LIX] from
Applied Biosystems, or were designed [interferon (IFN)-c,
TGF-b, CCL24⁄eotaxin-2, CCR3] as described previously.
26
Endogenous 18S rRNA was used to normalize the gene
expression between different samples.
Statistical analysis
The data were analysed with GraphPadPrism software (GraphPad,
San Diego, CA, U.S.A.) and the Mann–Whitney U-test was used
to compare mouse groups. The data are expressed as mean ±
SEM, and P <0 Æ05 was considered statistically signiﬁcant.
Results
Topical exposure to oxazolone induces enhanced
inﬁltration of neutrophils in the skin of
Smad3-deﬁcient mice
There was a signiﬁcant ear swelling response both in WT and
Smad3)⁄) mice that were exposed to oxazolone, measured at
24 and 48 h postallergen exposure (Fig. 1a). Also the weight
of ear pinnae increased after allergen exposure (Fig. 1b). The
magnitude of the swelling of ears in Smad3)⁄) mice did not
differ from that in WT mice.
Topical exposure to oxazolone induced a delayed-type
inﬂammation in the mouse skin, with increased inﬁltration of
inﬂammatory cells (Fig. 2a). Eosinophils (Fig. 2c) and T lym-
phocytes (CD3+, CD4+ cells; Fig. 2d, e) were signiﬁcantly
increased in oxazolone-exposed skin sites both in Smad3)⁄)
and WT mice, with a tendency towards increased numbers
of these cells in Smad3)⁄) mice. The number of neutroph-
ils was signiﬁcantly higher in oxazolone-exposed skin sites
in Smad3)⁄) mice (Fig. 2f, i, j) compared with WT mice
(Fig. 2f–h).
Proinﬂammatory, Th2 and regulatory cytokines are
increased in oxazolone-exposed Smad3-deﬁcient skin
mRNA of proinﬂammatory cytokines TNF-a and IL-1b was
signiﬁcantly increased in oxazolone-exposed skin samples
of Smad3-deﬁcient mice, compared with WT mice (Fig. 3a, b).
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Fig 1. Ear swelling responses after exposure to oxazolone (OXA).
Topical application of OXA to the ears induced signiﬁcant ear swelling
in wild-type (WT) and Smad3) ⁄) mice. The swelling of ears was
measured at 0, 24 and 48 h after topical exposure to OXA (a), and
ear auricles were weighed at 48 h postexposure (b). The results are
shown as mean ± SEM. **P <0 Æ01, ***P <0 Æ001.
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mediator of acute phase reactions, was also signiﬁcantly in-
creased at the mRNA level in Smad3-deﬁcient mice (Fig. 3c).
The expression of Th2 cytokine IL-4 mRNA (Fig. 3d), as
well as that of Th17 cell-derived cytokine IL-17 (Fig. 3e),
were signiﬁcantly increased in oxazolone-exposed skin of
Smad3-deﬁcient mice compared with their WT siblings. In
contrast, the major Th1 cytokine, IFN-c, was unaltered by the
lack of Smad3 (Fig. 3f).
The mRNA expression of TGF-b was signiﬁcantly increased
in Smad3-deﬁcient mice compared with WT mice after oxazo-
lone treatment (Fig. 4a). Also the expression of Treg-associ-
ated Foxp3 mRNA was markedly increased in Smad3)⁄)
mice (Fig. 4b). In line with the results at the mRNA level,
immunohistochemical staining showed increased numbers of
Foxp3+ cells in the skin in Smad3)⁄) mice (Fig. 4d, e). The
expression of IL-10 mRNA, an important regulatory cyto-
kine,
27,28 was not affected by the lack of Smad3 (Fig. 4c).
Cytokine proﬁles in draining lymph nodes differ
from the local response in the skin
Ear draining lymph nodes were signiﬁcantly larger in mice
that were exposed to oxazolone, and the proliferation rates of
lymph node cells from the oxazolone-exposed groups were
approximately ﬁvefold higher compared with control groups.
Lymph node size and rate of lymph node cell proliferation did
not differ between Smad3)⁄) mice and WT mice (Fig. 5a).
In the lymph nodes the pattern of IL-1b and IL-17 mRNA
expression was similar to that in the skin, i.e. they were
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Fig 2. Histological changes in the skin after
exposure to oxazolone (OXA). The number
of inﬂammatory cells (a) and the thickness
of epidermis (b) increased signiﬁcantly in
the skin after topical exposure to OXA in
wild-type (WT) and Smad3) ⁄) mice. Also
eosinophils (c), CD3+ (d) and CD4+ (e)
cells and neutrophils (f) increased during the
contact hypersensitivity response. HPF, high-
power ﬁeld. Haematoxylin and eosin-stained
skin sections show the signiﬁcantly increased
inﬁltration of neutrophils (arrows) in
Smad3) ⁄) mice (i, j) (original magniﬁcation
· 200, · 400, inset · 1000) compared
with WT (g, h) (original magniﬁcation
· 200, · 400). The numbers of CD3+
and CD4+ cells were determined by
immunohistochemical analysis. The results
are shown as mean ± SEM. *P <0 Æ05,
**P <0 Æ01.
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compared with WT mice after oxazolone exposure. Further,
there was a slight tendency for higher levels of TNF-a, IL-6
and TGF-b mRNA in Smad3)⁄) mice, although not statistic-
ally signiﬁcant (Fig. 5b–d). IL-4 and IFN-c mRNA levels, on
the contrary, tended to be lower in Smad3)⁄) mice lymph
nodes. In the Smad3)⁄) control group, the expression of
TGF-b mRNA was notably high, and there was also a tendency
towards increased levels of IL-10 and Foxp3 mRNA in the
lymph nodes, compared with WT control mice (Fig. 5d).
Expression of neutrophil-attracting and Th2 chemokines
is signiﬁcantly increased in the skin of Smad3-deﬁcient
mice
The mRNA expression of neutrophil-attracting chemokines CCL3
and CXCL5 was signiﬁcantly increased in oxazolone-treated
Smad3)⁄) mice compared with WT controls (Fig. 6a, b).
The expression of Th1-related chemokine CXCL10⁄IP10 was
unaltered by the lack of Smad3 in the skin of mice that were
exposed to oxazolone (Fig. 6c). Similarly, there was no
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Fig 3. mRNA expression of cytokines in the
skin after topical exposure to oxazolone
(OXA). mRNA of proinﬂammatory cytokines
interleukin (IL)-1b, tumour necrosis factor
(TNF)-a and IL-6 was signiﬁcantly increased
in OXA-exposed skin sites of Smad3) ⁄) mice
(a–c) compared with wild-type (WT), as well
as IL-4 and IL-17 mRNA (d, e). The
expression of interferon (IFN)-c mRNA
during the contact hypersensitivity response to
OXA was not modulated by the lack of Smad3
(f). The results are shown as mean ± SEM.
*P <0 Æ05, **P <0 Æ01, ***P <0 Æ001.
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(d) (e) Fig 4. mRNA expression of interleukin
(IL)-10, transforming growth factor (TGF)-b
and Foxp3, and Foxp3+ cells in the skin after
topical exposure to oxazolone (OXA). The
expression of TGF-b mRNA and Foxp3 mRNA
was signiﬁcantly increased in Smad3) ⁄) mice
compared with wild-type (WT) (a, b). The
expression of IL-10 mRNA in the skin was
not affected by the lack of Smad3 (c).
Immunohistochemical analysis of Foxp3+
cells (arrows) in OXA-treated skin in WT (d)
and Smad3) ⁄) mice (e). (a–c) The results
are shown as mean ± SEM. *P <0 Æ05,
**P <0 Æ01, ***P <0 Æ001.
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550 The role of Smad3 in the CHS response to oxazolone, M. Anthoni et al.difference in the expression of CXCL9⁄MIG, another Th1-
related chemokine (data not shown). However, the expression
of Th2-associated chemokine CCL24 (eotaxin-2) was signiﬁ-
cantly increased in Smad3-deﬁcient mice compared with WT
mice (Fig. 6d). Further, the expression of CCR3, a receptor for
CCL24, was also signiﬁcantly increased in Smad3)⁄) mice
when compared with WT controls (Fig. 6e).
Discussion
Targeted disruption of Smad3 in mice results in immune
dysregulation and susceptibility to opportunistic infection.
Smad3-deﬁcient T cells show an activated phenotype in vivo,
and reduced responsiveness to TGF-b in vitro.
19 It has also
been demonstrated that Smad3-null splenocytes have defects
in TGF-b-mediated repression of cytokine production.
21 In
various disease models, in the lack of Smad3, wound heal-
ing was accelerated,
20 the ﬁbrotic response to bleomycin in
mouse lungs was attenuated
29 and our laboratory has recent-
ly shown that the response to topical exposure to ovalbumin
is diminished when Smad3 is lacking in the mouse atopic
dermatitis model.
30 In the present study, Smad3 deﬁci-
ency greatly increased the expression of proinﬂammatory,
Th2 and Th17 type cytokines and chemokines and regula-
tory components such as TGF-b and Foxp3 in the skin, as
well as neutrophil inﬁltration during the CHS response to
oxazolone.
Proinﬂammatory cytokines are upregulated to a certain
degree in local trauma. Stimulation with proinﬂammatory
cytokines induces adhesion molecules,
31 which facilitate, or
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Fig 5. Lymph node (LN) size, proliferation,
and mRNA expression of cytokines and Foxp3.
LN cell proliferation and size (a)
were increased in oxazolone (OXA)-exposed
mice. The expression of interleukin (IL)-1b
(b) and IL-17 (c) mRNA was signiﬁcantly
increased in Smad3) ⁄) lymph nodes after
exposure to OXA, compared with wild-type
(WT), while that of tumour necrosis factor
(TNF)-a, IL-6, IL-4 and interferon (IFN)-c was
not (b, c). Transforming growth factor (TGF)-
b mRNA expression in the LNs of vehicle-
treated mice was signiﬁcantly higher in
Smad3) ⁄) mice (d). The results are shown as
mean ± SEM. *P <0 Æ05, **P <0 Æ01.
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4 According to pre-
vious studies, TGF-b secretion inhibits the production of
inﬂammatory cytokines and chemokines in macrophages,
including IL-1b, TNF-a and IL-8.
32 Conversely, Smad3 deﬁ-
ciency renders immune cells insensitive to such inhibition.
21
We observed signiﬁcantly increased production of proinﬂam-
matory cytokines IL-6, IL-1b and TNF-a at the mRNA level in
skin sites that were exposed to oxazolone in the Smad3-
deﬁcient mice. An increased expression of inﬂammatory cyto-
kines was also detectable in the draining lymph nodes of the
Smad3)⁄) mice, although at less striking levels than in the
skin (Fig. 5b).
The general concept is that CHS is mediated by IFN-c-
producing CD8+ T cells, while IL-2-, IL-4- and IL-10-
producing CD4+ T cells regulate the response. There are,
however, results that also indicate an effector role for CD4+
T cells in the CHS response to oxazolone in C57BL6 mice.
33
In addition, the Th2 type cytokine IL-4 might also have a
proinﬂammatory role, as shown by impaired CHS responses
in mice lacking IL-4.
7 In this study, the level of IL-4 mRNA
in the skin of Smad3)⁄) mice was strongly increased after
exposure to oxazolone, while the expression of IFN-c
remained at the same level in Smad3)⁄) mice as in their
WT siblings (Fig. 3d, f). Thus, IFN-c production by, presum-
ably, mainly CD8+ T cells in this model
33 is not affected by
the lack of Smad3. In contrast, the production of IL-4,
mainly by CD4+ T cells, according to previous ﬁndings,
33 is
strongly modulated by the lack of Smad3.
Several studies have shown that TGF-b can inhibit both Th1
and Th2 differentiation in vitro, and that Th2 differentiation is
more sensitive to inhibition by TGF-b.
9 Studies with Smad3-
deﬁcient immune cells have shown that Smad3)⁄) T cells
have an activated phenotype in vivo, and that Smad3)⁄) spleen
cells have defective TGF-b-mediated inhibition of cytokine
production in vitro.
19,21 Thus, the signiﬁcantly increased pro-
duction of IL-4 mRNA in Smad3)⁄) skin after oxazolone
exposure might be a consequence of reduced inhibition of
IL-4 production by TGF-b, or increased conversion of CD4+ T
cells into IL-4-producing Th2 cells. Moreover, there was a
slight tendency towards increased numbers of CD3+ and
CD4+ cells in the skin of Smad3)⁄) mice, which also could
contribute to the increased expression of IL-4. Nevertheless,
the expression of high levels of IL-4 mRNA after oxazolone
exposure was restricted to the skin and was not detected in
the lymph nodes in Smad3)⁄) mice.
IL-1b, IL-6 and TGF-b are essential for the differentiation of
Th17 cells in mice.
14 After exposure to oxazolone, all three of
them were signiﬁcantly increased at the mRNA level in the
skin in Smad3)⁄) mice, and they were also abundant in
lymph nodes. We consequently found increased levels of IL-
17, product of Th17 cells, both in the skin and in the lymph
nodes of Smad3)⁄) mice during the CHS response to oxazo-
lone. IL-17 is important in CHS, as demonstrated by reduced
CHS in mice that lack IL-17.
34 Hapten primed T cells produce
IL-17, and in particular a CD8+ subpopulation of T cells that
produce IL-17 has been demonstrated as important for the
elicitation of CHS responses.
13 Our results suggest that Smad3
is involved in the regulation of IL-17 in the CHS response to
oxazolone.
TGF-b plays a crucial role in skin-induced tolerance and is
important in the induction of Tregs that inhibit CHS.
35
TGF-b is needed to maintain normal peripheral Treg num-
bers
36 and TGF-b signalling enhances the conversion of naive
T cells into Tregs.
37 Although Smad3 has recently been
implicated as an important enhancer of Foxp3 expression,
38
in our study the lack of Smad3 in knockout mice did not
result in reduced, but rather increased expression of Foxp3
mRNA and elevated numbers of Foxp3+ cells in the skin
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Fig 6. Chemokine and chemokine receptor mRNA expression in the
skin after topical exposure to oxazolone (OXA). Neutrophil-attracting
chemokines CCL3 ⁄MIP-1a (a) and CXCL5 ⁄LIX (b) were signiﬁcantly
increased in OXA-treated Smad3) ⁄) mice compared with wild-
type (WT). The expression of Th2-associated chemokine CCL24
(eotaxin-2) was signiﬁcantly increased in OXA-treated Smad3) ⁄)
mice compared with WT (d), while that of Th1-related chemokine
CXCL10 ⁄IP10 was not (c). The expression of Th2-associated
chemokine receptor CCR3 was signiﬁcantly increased in Smad3) ⁄)
mice compared with WT (e). The results are shown as mean ± SEM.
*P <0 Æ05, **P <0 Æ01, ***P <0 Æ001.
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there are other than Smad3-dependent pathways of Foxp3
induction at the site of inﬂammation. Our results also indi-
cate that IL-10 is not involved in that pathway. Notably, in
the lymph nodes of Smad3)⁄) control mice, there was a
high level of TGF-b expression, and a tendency for increased
expression of IL-10 and Foxp3 (Fig. 5b–d) compared with
WT, suggesting increased regulatory activity in general in
mice that lack Smad3.
The CCR3 receptor is expressed predominately by eosino-
phils, and to a smaller extent by basophils and Th2 polarized
lymphocytes,
39 which are all relevant to allergic inﬂammation.
CCR3 ligands, such as the Th2-associated CCL24⁄eotaxin-2,
amplify the Th2 response in allergic inﬂammation. In this
study, the mRNA of both CCR3 and CCL24 was signiﬁcantly
elevated in the skin of oxazolone-challenged Smad3)⁄) mice,
which may reﬂect the slight (although not statistically signiﬁ-
cant) increase of eosinophil inﬁltration in the skin of
Smad3)⁄) mice.
During acute inﬂammation, an initial inﬁltration of neu-
trophils characterizes the leucocyte recruitment, being later
replaced by monocytes, lymphocytes and other inﬂammatory
cells.
40 According to earlier studies, Smad3 deﬁciency impairs
the chemotactic response of neutrophils to TGF-b in vitro.
19
Accordingly, in wound healing experiments, both neutrophils
and monocytes were largely absent in mice lacking Smad3.
20
In contrast to these ﬁndings, we observed that during the CHS
response to oxazolone there is a signiﬁcantly increased neutro-
phil inﬁltration into the skin of mice that lack Smad3. We also
analysed the expression levels of chemokines CCL3⁄MIP-1a
and CXCL5⁄LIX, which are both involved in neutrophil
recruitment,
41–47 and both of these chemokines were signiﬁ-
cantly increased at the mRNA level in oxazolone-exposed skin
of Smad3)⁄) mice. It has been demonstrated that TGF-b
inhibits CCL3 expression, mediated via Smad3 in macrophages
in vitro,
48 which might explain our observations of increased
CCL3 as well as CXCL5 during the CHS response in Smad3)⁄)
mice. The increased levels of attracting chemokines (CCL3 and
CXCL5), in turn, might bring about the increased inﬁltration
of neutrophils into the skin. Evidence is also accumulating that
IL-17, which was signiﬁcantly increased in Smad3-deﬁcient
lymph nodes and skin during the oxazolone response,
signiﬁcantly stimulates neutrophil maturation, migration and
function.
49
In conclusion, our results suggest that Smad3-mediated sig-
nalling pathways play an important part in the CHS response
to oxazolone. Complete loss of this signalling intermediate
resulted in accelerated expression of proinﬂammatory, Th17
and Th2 type cytokines in the skin, as well as increased inﬁl-
tration of neutrophils to the site of inﬂammation. Moreover,
the lack of Smad3 in knockout mice did not result in reduced,
but rather increased expression of Foxp3 mRNA and elevated
numbers of Foxp3+ cells in the skin during the CHS response.
Unravelling the mechanisms in TGF-b-mediated regulation of
CHS may provide insights for future prevention and treatment
modalities in this often disabling disease.
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